Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A P...

by Baecher-Allan, C.M, Chen, K., Cortina, A.S, Da Mata, R.G, De Paula, G.S, Dedivitis, R.A, Healey, B.C, Izzy, S., Jacob, J., Keppeke, G.D, Matos, K.T.F, Moreira, T.G, Palejwala, V., Pansera, F.C, Rezende, R.M, Santana, T.M.M, Shailubhai, K., Spinola, M.G, Weiner, H.L
Published 2022